These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2862009)

  • 1. Pantethine, a cysteamine precursor, depletes immunoreactive somatostatin and prolactin in the rat.
    Reichlin S; Bollinger-Gruber JA
    Endocrinology; 1985 Aug; 117(2):492-5. PubMed ID: 2862009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in oxytocin and vasopressin content in posterior pituitary and hypothalamus following pantethine treatment.
    Ong GL; Miaskowski C; Haldar J
    Life Sci; 1990; 47(6):503-6. PubMed ID: 2402177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin in rat tissues is depleted by cysteamine administration.
    Szabo S; Reichlin S
    Endocrinology; 1981 Dec; 109(6):2255-7. PubMed ID: 6118261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteamine and pantethine effects on passive avoidance behavior, shuttle box learning, open-field activity, striatal catecholamines and somatostatin.
    Vécsei L; Widerlöv E; Ekman R; Alling C
    Arch Int Pharmacodyn Ther; 1989; 299():14-27. PubMed ID: 2570553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cysteamine and pantethine on open-field behavior, hypothalamic catecholamine concentrations, and somatostatin-induced barrel rotation in rats.
    Vécsei L; Alling C; Heilig M; Widerlöv E
    Pharmacol Biochem Behav; 1989 Mar; 32(3):629-35. PubMed ID: 2568000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pantethine and cystamine deplete cystine from cystinotic fibroblasts via efflux of cysteamine-cysteine mixed disulfide.
    Butler JD; Zatz M
    J Clin Invest; 1984 Aug; 74(2):411-6. PubMed ID: 6746900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The depletion of plasma prolactin by pantethine in oestrogen-primed hyperprolactinaemic rats.
    Jeitner TM; Oliver JR
    J Endocrinol; 1990 Mar; 124(3):397-402. PubMed ID: 2332716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of pantethine in cystinosis.
    Wittwer CT; Gahl WA; Butler JD; Zatz M; Thoene JG
    J Clin Invest; 1985 Oct; 76(4):1665-72. PubMed ID: 4056044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies of intracerebroventricularly administered cysteamine and pantethine in different behavioral tests and on brain catecholamines in rats.
    Vécsei L; Alling C; Widerlöv E
    Arch Int Pharmacodyn Ther; 1990; 305():140-51. PubMed ID: 2241425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pantethine, cysteamine and pantothenic acid on open-field behavior and brain catecholamines in rats.
    Vécsei L; Widerlöv E; Alling C
    Arch Int Pharmacodyn Ther; 1989; 300():14-21. PubMed ID: 2619420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pantethine, a somatostatin depleting agent, increases food intake in rats.
    Abucham J; Bollinger-Gruber J; Reichlin S
    Pharmacol Biochem Behav; 1989 Jul; 33(3):585-9. PubMed ID: 2587601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin depleting potency of cysteamine-related thiols and amines in the rat: structure-activity relation.
    Szabo S; Reichlin S; Bollinger-Gruber JA; Brown A
    J Pharmacol Exp Ther; 1992 Nov; 263(2):752-6. PubMed ID: 1359114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteamine-induced depletion of somatostatin and prolactin.
    Millard WJ; Sagar SM; Martin JB
    Fed Proc; 1985 Jun; 44(9):2546-50. PubMed ID: 2860016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OLD AND NEW NEUROENDOCRINE MOLECULES: SOMATOSTATIN, CYSTEAMINE, PANTETHINE AND KYNURENINE.
    Vécsei L; Horváth Z; Tuka B
    Ideggyogy Sz; 2014 Mar; 67(3-4):107-12. PubMed ID: 26118251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical and clinical studies with cysteamine and pantethine related to the central nervous system.
    Vécsei L; Widerlöv E
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(6):835-62. PubMed ID: 2277850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pantethine lipomodulation: evidence for cysteamine mediation in vitro and in vivo.
    Wittwer CT; Graves CP; Peterson MA; Jorgensen E; Wilson DE; Thoene JG; Wyse BW; Windham CT; Hansen RG
    Atherosclerosis; 1987 Nov; 68(1-2):41-9. PubMed ID: 3689482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose- and time-response effects of pantethine on open-field behavior, and on central neurotransmission in rats.
    Vécsei L; Widerlöv E; Ekman R; Alling C
    Pharmacol Biochem Behav; 1990 Jan; 35(1):165-70. PubMed ID: 1969162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin depletion by cysteamine: mechanism and implication for duodenal ulceration.
    Szabo S; Reichlin S
    Fed Proc; 1985 Jun; 44(9):2540-5. PubMed ID: 2860015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteamine depletes prolactin (PRL) but does not alter the structure of PRL-containing granules in the anterior pituitary.
    Weinstein LA; Landis DM; Sagar SM; Millard WJ; Martin JB
    Endocrinology; 1984 Oct; 115(4):1543-50. PubMed ID: 6479101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin depletion of the gut and pancreas induced by cysteamine is not prevented by vagotomy or by dopamine agonists.
    Szabo S; Reichlin S
    Regul Pept; 1983 Apr; 6(1):43-9. PubMed ID: 6135242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.